997 related articles for article (PubMed ID: 27810654)
21. Nonmedical prescription sedative/tranquilizer use in alcohol and opioid use disorders.
Votaw VR; Witkiewitz K; Valeri L; Bogunovic O; McHugh RK
Addict Behav; 2019 Jan; 88():48-55. PubMed ID: 30142484
[TBL] [Abstract][Full Text] [Related]
22. Opioid Use Disorder and Prescribed Opioid Regimens: Evidence from Commercial and Medicaid Claims, 2005-2015.
Ali MM; Cutler E; Mutter R; Henke RM; O'Brien PL; Pines JM; Mazer-Amirshahi M; Diou-Cass J
J Med Toxicol; 2019 Jul; 15(3):156-168. PubMed ID: 31152355
[TBL] [Abstract][Full Text] [Related]
23. US hospital discharges documenting patient opioid use disorder without opioid overdose or treatment services, 2011-2015.
Peterson C; Xu L; Mikosz CA; Florence C; Mack KA
J Subst Abuse Treat; 2018 Sep; 92():35-39. PubMed ID: 30032942
[TBL] [Abstract][Full Text] [Related]
24. Clinical characteristics of treatment-seeking prescription opioid vs. heroin-using adolescents with opioid use disorder.
Subramaniam GA; Stitzer MA
Drug Alcohol Depend; 2009 Apr; 101(1-2):13-9. PubMed ID: 19081205
[TBL] [Abstract][Full Text] [Related]
25. Treatment use, sources of payment, and financial barriers to treatment among individuals with opioid use disorder following the national implementation of the ACA.
McKenna RM
Drug Alcohol Depend; 2017 Oct; 179():87-92. PubMed ID: 28763780
[TBL] [Abstract][Full Text] [Related]
26. Developing a clinical decision support for opioid use disorders: a NIDA center for the clinical trials network working group report.
Bart GB; Saxon A; Fiellin DA; McNeely J; Muench JP; Shanahan CW; Huntley K; Gore-Langton RE
Addict Sci Clin Pract; 2020 Jan; 15(1):4. PubMed ID: 31948487
[TBL] [Abstract][Full Text] [Related]
27. The role of substance use disorders in experiencing a repeat opioid overdose, and substance use treatment patterns among patients with a non-fatal opioid overdose.
Karmali RN; Ray GT; Rubinstein AL; Sterling SA; Weisner CM; Campbell CI
Drug Alcohol Depend; 2020 Apr; 209():107923. PubMed ID: 32126455
[TBL] [Abstract][Full Text] [Related]
28. Illicit and nonmedical drug use among Asian Americans, Native Hawaiians/Pacific Islanders, and mixed-race individuals.
Wu LT; Blazer DG; Swartz MS; Burchett B; Brady KT;
Drug Alcohol Depend; 2013 Dec; 133(2):360-7. PubMed ID: 23890491
[TBL] [Abstract][Full Text] [Related]
29. Opioid-related treatment, interventions, and outcomes among incarcerated persons: A systematic review.
Malta M; Varatharajan T; Russell C; Pang M; Bonato S; Fischer B
PLoS Med; 2019 Dec; 16(12):e1003002. PubMed ID: 31891578
[TBL] [Abstract][Full Text] [Related]
30. Associations Between the Specialty of Opioid Prescribers and Opioid Addiction, Misuse, and Overdose Outcomes.
Lobo CP; Cochran G; Chang CH; Gellad WF; Gordon AJ; Jalal H; Lo-Ciganic WH; Karp JF; Kelley D; Donohue JM
Pain Med; 2020 Sep; 21(9):1871-1890. PubMed ID: 31626295
[TBL] [Abstract][Full Text] [Related]
31. Characteristics of Adults Aged ≥18 Years Evaluated for Substance Use and Treatment Planning - United States, 2019.
Kacha-Ochana A; Jones CM; Green JL; Dunphy C; Govoni TD; Robbins RS; Guy GP
MMWR Morb Mortal Wkly Rep; 2022 Jun; 71(23):749-756. PubMed ID: 35679167
[TBL] [Abstract][Full Text] [Related]
32. The nexus of opioids, pain, and addiction: Challenges and solutions.
Henningfield JE; Ashworth JB; Gerlach KK; Simone B; Schnoll SH
Prev Med; 2019 Nov; 128():105852. PubMed ID: 31634511
[TBL] [Abstract][Full Text] [Related]
33. Postpartum Opioid-Related Mortality in Patients With Public Insurance.
Suarez EA; Huybrechts KF; Straub L; Hernández-Díaz S; Creanga AA; Connery HS; Gray KJ; Vine SM; Jones HE; Bateman BT
Obstet Gynecol; 2023 Apr; 141(4):657-665. PubMed ID: 36897177
[TBL] [Abstract][Full Text] [Related]
34. Behavioral health treatment utilization among individuals with co-occurring opioid use disorder and mental illness: Evidence from a national survey.
Novak P; Feder KA; Ali MM; Chen J
J Subst Abuse Treat; 2019 Mar; 98():47-52. PubMed ID: 30665603
[TBL] [Abstract][Full Text] [Related]
35. Associations between Medication Assisted Therapy Services Delivery and Mortality in a National Cohort of Veterans with Posttraumatic Stress Disorder and Opioid Use Disorder.
Riblet NB; Gottlieb DJ; Shiner B; Cornelius SL; Watts BV
J Dual Diagn; 2020; 16(2):228-238. PubMed ID: 31852392
[No Abstract] [Full Text] [Related]
36. The dynamics of heroin and illicit opioid use disorder, casual use, treatment, and recovery: A mathematical modeling analysis.
Cole S; Olive MF; Wirkus S
Math Biosci Eng; 2024 Feb; 21(2):3165-3206. PubMed ID: 38454724
[TBL] [Abstract][Full Text] [Related]
37. Controlled Substance Prescribing Patterns--Prescription Behavior Surveillance System, Eight States, 2013.
Paulozzi LJ; Strickler GK; Kreiner PW; Koris CM;
MMWR Surveill Summ; 2015 Oct; 64(9):1-14. PubMed ID: 26469747
[TBL] [Abstract][Full Text] [Related]
38. Commentary: The opioid overdose epidemic: Evidence-based interventions.
Barglow P
Am J Addict; 2018 Dec; 27(8):605-607. PubMed ID: 30311993
[TBL] [Abstract][Full Text] [Related]
39. Investigating the Social Ecological Contexts of Opioid Use Disorder and Poisoning Hospitalizations in Pennsylvania.
Mair C; Sumetsky N; Burke JG; Gaidus A
J Stud Alcohol Drugs; 2018 Nov; 79(6):899-908. PubMed ID: 30573021
[TBL] [Abstract][Full Text] [Related]
40. Use of Drug Treatment Services Among Adults With Opioid Use Disorder: Rates, Patterns, and Correlates.
Rhee TG; Rosenheck RA
Psychiatr Serv; 2019 Nov; 70(11):992-999. PubMed ID: 31357922
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
